Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

NCT: NCT06634719 · RECRUITING

NCT IDNCT06634719
StatusRECRUITING
Start Date2025-02-01
Completion2026-06-30

Brief Summary

This is a prospective, multicenter, single-arm interventional feasibility study to evaluate the safety and feasibility of the Juveena Hydrogel System for temporary control of heavy menstrual bleeding (HMB) in women with a history of chronic ovulatory HMB.

Frequently Asked Questions

What is Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)?

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB) is a clinical trial registered under NCT06634719. Current status: RECRUITING.

What is the status of NCT06634719?

The current status of NCT06634719 (Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)) is: RECRUITING.

When did Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB) start?

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB) started on 2025-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑